Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes

被引:15
作者
Kheniser, Karim G. [1 ]
Osme, Abdullah [2 ]
Kim, Chunki [2 ]
Ilchenko, Serguei [2 ]
Kasumov, Takhar [2 ]
Kashyap, Sangeeta R. [1 ]
机构
[1] Cleveland Clin, Dept Endocrinol & Metab, 9500 Euclid Ave, Cleveland, OH 44195 USA
[2] Northeast Ohio Med Univ, Dept Pharmaceut Sci, 4209 St R,POB 95, Rootstown, OH 44272 USA
基金
美国国家卫生研究院;
关键词
HDL dysfunction; heavy water; proteomics; type; 2; diabetes; apolipoproteins; APOLIPOPROTEIN-A-I; REVERSE CHOLESTEROL TRANSPORT; HDL CHOLESTEROL; INSULIN-RESISTANCE; MASS-SPECTROMETRY; EFFLUX; ADIPONECTIN; KINETICS; DYSFUNCTION; COMPLEMENT;
D O I
10.3390/biom10040520
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the effect of mild hyperglycemia on high-density lipoprotein (HDL) metabolism and kinetics in diet-controlled subjects with type 2 diabetes (T2D). (H2O)-H-2-labeling coupled with mass spectrometry was applied to quantify HDL cholesterol turnover and HDL proteome dynamics in subjects with T2D (n = 9) and age- and BMI-matched healthy controls (n = 8). The activities of lecithin-cholesterol acyltransferase (LCAT), cholesterol ester transfer protein (CETP), and the proinflammatory index of HDL were quantified. Plasma adiponectin levels were reduced in subjects with T2D, which was directly associated with suppressed ABCA1-dependent cholesterol efflux capacity of HDL. The fractional catabolic rates of HDL cholesterol, apolipoprotein A-II (ApoA-II), ApoJ, ApoA-IV, transthyretin, complement C3, and vitamin D-binding protein (all p < 0.05) were increased in subjects with T2D. Despite increased HDL flux of acute-phase HDL proteins, there was no change in the proinflammatory index of HDL. Although LCAT and CETP activities were not affected in subjects with T2D, LCAT was inversely associated with blood glucose and CETP was inversely associated with plasma adiponectin. The degradation rates of ApoA-II and ApoA-IV were correlated with hemoglobin A(1c). In conclusion, there were in vivo impairments in HDL proteome dynamics and HDL metabolism in diet-controlled patients with T2D.
引用
收藏
页数:16
相关论文
共 66 条
[1]   Influence of atorvastatin on apolipoprotein E and Al kinetics in patients with type 2 diabetes [J].
Bach-Ngohou, K ;
Ouguerram, K ;
Frénais, R ;
Maugère, P ;
Piquer, BR ;
Zaïr, Y ;
Krempf, M ;
Bard, JM .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (01) :363-369
[2]   Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].
Boden, William E. ;
Probstfield, Jeffrey L. ;
Anderson, Todd ;
Chaitman, Bernard R. ;
Desvignes-Nickens, Patrice ;
Koprowicz, Kent ;
McBride, Ruth ;
Teo, Koon ;
Weintraub, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267
[3]   Hydrazine compounds inhibit glycation of low-density lipoproteins and prevent the in vitro formation of model foam cells from glycolaldehyde-modified low-density lipoproteins [J].
Brown, BE ;
Mahroof, FM ;
Cook, NL ;
van Reyk, DM ;
Davies, MJ .
DIABETOLOGIA, 2006, 49 (04) :775-783
[4]   Influence of C3 deficiency on atherosclerosis [J].
Buono, C ;
Come, CE ;
Witztum, JL ;
Maguire, GF ;
Connelly, PW ;
Carroll, M ;
Lichtman, AH .
CIRCULATION, 2002, 105 (25) :3025-3031
[5]   Apolipoprotein A-II: Evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis [J].
Chan, Dick C. ;
Ng, Theodore W. K. ;
Watts, Gerald F. .
ANNALS OF MEDICINE, 2012, 44 (04) :313-324
[6]   Very Low Density Lipoprotein Metabolism and Plasma Adiponectin as Predictors of High-Density Lipoprotein Apolipoprotein A-I Kinetics in Obese and Nonobese Men [J].
Chan, Dick C. ;
Barrett, P. Hugh R. ;
Ooi, Esther M. M. ;
Ji, Juying ;
Chan, Doris T. ;
Watts, Gerald F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (03) :989-997
[7]   Kinetics of preβ1 HDL and αHDL in type II diabetic patients [J].
Chétiveaux, M ;
Lalanne, F ;
Lambert, G ;
Zair, Y ;
Ouguerram, K ;
Krempf, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (01) :29-34
[8]   A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients [J].
Cubedo, Judit ;
Padro, Teresa ;
Garcia-Arguinzonis, Maisa ;
Vilahur, Gemma ;
Minambres, Inka ;
Pou, Jose Maria ;
Ybarra, Juan ;
Badimon, Lina .
JOURNAL OF LIPID RESEARCH, 2015, 56 (09) :1762-1773
[9]   Protection against atherogenesis in mice mediated by human apolipoprotein A-IV [J].
Duverger, N ;
Tremp, G ;
Caillaud, JM ;
Emmanuel, F ;
Castro, G ;
Fruchart, JC ;
Steinmetz, A ;
Denefle, P .
SCIENCE, 1996, 273 (5277) :966-968
[10]  
Farbstein D, 2012, EXPERT REV CARDIOVAS, V10, P353, DOI [10.1586/erc.11.182, 10.1586/ERC.11.182]